Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
The human 2-oxoglutarate dependent oxygenase aspartate/asparagine-β-hydroxylase (AspH) catalyses the hydroxylation of Asp/Asn-residues in epidermal growth factor-like domains (EGFDs). AspH is upregulated on the surface of malign cancer cells; increased AspH levels correlate with tumour invasiveness....
Main Authors: | Brewitz, L, Tumber, A, Pfeffer, I, McDonough, M, Schofield, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Research
2020
|
Similar Items
-
Synthesis of novel pyridine-carboxylates as small-molecule inhibitors of human aspartate/asparagine-β-hydroxylase
by: Brewitz, L, et al.
Published: (2020) -
Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing
by: Brewitz, L, et al.
Published: (2020) -
Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase
by: Brewitz, L, et al.
Published: (2020) -
Novel 2-oxoglutarate analogues modulate the epigenetic activity of the cancer-related human enzyme aspartate/asparagine-β-hydroxylase
by: Brewitz, L, et al.
Published: (2020) -
Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylas
by: Brewitz, L, et al.
Published: (2020)